Related Experiment Video
Updated: Dec 13, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
METTL3 May Regulate Testicular Germ Cell Tumors Through EMT and Immune Pathways
Yang Luo1,2,3,4, Yuan Sun1,2,3,4, Lei Li1,2,3,4
1Center for Reproductive Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Abstract:
Testicular germ cell tumors (TGCTs) are highly prevalent in young men aged 20-40 years and are one of the most common lethal solid tumors in men of this age. Due to the current unclear mechanism of tumor development, there is a lack of effective treatment, and therefore in-depth research of the molecular mechanism of the occurrence and development of TGCT and the search for suitable and effective therapeutic targets and molecular markers are of great significance for achieving effective treatment. METTL3 is a very important methylase, which has been implicated in the progression of many cancers, but the role of METTL3 in TGCT has not been fully elucidated. In this article, we found that METTL3 expression was significantly downregulated in TGCT tissues, and patients with low expression levels had lower overall survival and relapse-free survival rates. After overexpressing METTL3, cell proliferation, invasion, and migration ability significantly increased, while influencing the expression of epithelial-mesenchymal transition (EMT)-related proteins. In addition, we observed that the expression level of METTL3 positively correlated with molecular markers and infiltration level of CD8+ and CD4+ T cells and natural killer cells. In sum, our findings identified that METTL3 can be used as an independent prognostic marker in patients with TGCT. METTL3 participates in the proliferation, migration, and invasion of TGCT cells by regulating the expression of EMT-related genes and may also play a role in activating the tumor immune response in TGCT.
Insights
METTL3 expression is reduced in testicular germ cell tumors (TGCTs), impacting patient survival. Upregulating METTL3 enhances tumor cell invasion and migration, suggesting its role as a prognostic marker and potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Testicular germ cell tumors (TGCTs) are prevalent in young men, with unclear development mechanisms and limited effective treatments.
- Research into molecular mechanisms and therapeutic targets for TGCT is crucial for improving patient outcomes.
- The role of METTL3, a key methylase involved in various cancers, in TGCT progression remains largely unelucidated.
Purpose of the Study:
- To investigate the role of METTL3 in the occurrence and development of TGCT.
- To determine if METTL3 can serve as a prognostic marker for TGCT patients.
- To explore the impact of METTL3 on TGCT cell behavior and the tumor immune microenvironment.
Main Methods:
- Analysis of METTL3 expression levels in TGCT tissues.
- Overexpression of METTL3 in TGCT cells to assess functional changes.
- Evaluation of cell proliferation, invasion, and migration.
- Assessment of epithelial-mesenchymal transition (EMT)-related protein expression.
- Correlation analysis between METTL3 expression and immune cell infiltration (CD8+ T cells, CD4+ T cells, NK cells).
Main Results:
- METTL3 expression was significantly downregulated in TGCT tissues.
- Low METTL3 expression correlated with poorer overall survival and relapse-free survival rates.
- METTL3 overexpression increased TGCT cell proliferation, invasion, and migration, affecting EMT-related proteins.
- METTL3 expression positively correlated with CD8+ T cell, CD4+ T cell, and natural killer cell infiltration.
Conclusions:
- METTL3 functions as an independent prognostic marker for TGCT patients.
- METTL3 influences TGCT cell proliferation, migration, and invasion via regulation of EMT-related genes.
- METTL3 may play a role in modulating the tumor immune response within the TGCT microenvironment.
Related Concept Videos
The Tumor Microenvironment
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

